Acrivon Therapeutics, Inc. (ACRV) research
Acrivon Therapeutics, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.85
- As of
Acrivon Therapeutics, Inc. (ACRV): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-12.
As of . Source: SEC EDGAR filings for ACRV. Method and limitations.
Share the ACRV intelligence card
See ACRV live in the terminal
Track ACRV's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live ACRV terminal, freeActive signals for ACRV
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 59% of ACRV (2026Q2)
- highINSTITUTIONAL_SURGE
TWO SIGMA INVESTMENTS, LP added +65% to ACRV (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 59% of ACRV (2026Q2)
- highINSTITUTIONAL_SURGE
TWO SIGMA INVESTMENTS, LP added +65% to ACRV (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 59% of ACRV (2026Q2)
FREE, NO ACCOUNT
Every signal on ACRV, as it fires
You are seeing 5 of 11 signals recorded on ACRV since 2026-06-21.
The five above landed across 2 days. The other 6 were recorded on 1 other days. 7 of the 11 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in ACRV (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 004890109 · 2026Q2 | $1.4M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 004890109 · 2026Q2 | $1.1M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 004890109 · 2026Q2 | $73K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, ACRV
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
See more ACRV signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ACRVand get the insider, 13F, options, and confluence read in one view.